We evaluated the diagnostic implications of substitution of serum type I procollagen C terminal peptide (PIC) for type III procollagen N terminal peptide (PIIIN) for assessment of liver fibrosis in viral and alcoholic liver diseases. Fourty normal subjects, 138 patients with viral liver diseases and 43 with alcoholic liver diseases were investigated. In patients with fatty liver and viral acute hepatitis, the mean PIC values were not significantly different from the normal value. The mean serum values and positive ratio of PIC in chronic hepatitis and viral liver cirrhosis were both increased in proportion to degree of liver fibrosis. The same pattern was also observed in alcoholic liver fibrosis and alcoholic liver cirrhosis. Although the ...
textabstractChronic liver disease is often associated with deposition of fibrous tissue, a process ...
International audienceWe have recently described a fibrosis index combining serum procollagen type I...
Sera from 64 patients with HBsAg-negative chronic liver disease with or without cirrhosis were inves...
We evaluated the diagnostic implications of substitution of serum type I procollagen C terminal pept...
Introduction : N-terminal propeptide of procollagen type III (PIIINP) is generated during the synthe...
To assess the value of type III procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera f...
C-terminal peptide of procollagen I, N-terminal peptide of procollagen III, collagen IV and serum pr...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
The clinical significance of serum procollagen type III peptide, a marker of active fibrogenesis, wa...
The clinical significance of serum procollagen type III peptide, a marker of active fibrogenesis, wa...
Hepatic fibroplasia seems to play an important role in the course of primary liver cancer (PLC) sinc...
Liver biopsy is the reference standard for the detection of nonalcoholic steatohepatitis (NASH) with...
Hepatic fibroplasia seems to play an important role in the course of primary liver cancer (PLC) sinc...
textabstractChronic liver disease is often associated with deposition of fibrous tissue, a process ...
International audienceWe have recently described a fibrosis index combining serum procollagen type I...
Sera from 64 patients with HBsAg-negative chronic liver disease with or without cirrhosis were inves...
We evaluated the diagnostic implications of substitution of serum type I procollagen C terminal pept...
Introduction : N-terminal propeptide of procollagen type III (PIIINP) is generated during the synthe...
To assess the value of type III procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera f...
C-terminal peptide of procollagen I, N-terminal peptide of procollagen III, collagen IV and serum pr...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
Objective: High serum levels of carboxy-terminal propeptide of Type 1 procollagen (PICP) were report...
The clinical significance of serum procollagen type III peptide, a marker of active fibrogenesis, wa...
The clinical significance of serum procollagen type III peptide, a marker of active fibrogenesis, wa...
Hepatic fibroplasia seems to play an important role in the course of primary liver cancer (PLC) sinc...
Liver biopsy is the reference standard for the detection of nonalcoholic steatohepatitis (NASH) with...
Hepatic fibroplasia seems to play an important role in the course of primary liver cancer (PLC) sinc...
textabstractChronic liver disease is often associated with deposition of fibrous tissue, a process ...
International audienceWe have recently described a fibrosis index combining serum procollagen type I...
Sera from 64 patients with HBsAg-negative chronic liver disease with or without cirrhosis were inves...